Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Jen Culton learned she had the BRCA1 gene mutation after her older sister's breast-cancer diagnosis. She decided to have two of her daughters tested; one daughter also has the BRCA1 gene mutation.

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Jen Culton learned she had the BRCA1 gene mutation after her older sister's breast-cancer diagnosis. She decided to have two of her daughters tested; one daughter also has the BRCA1 gene mutation.

The conclusions for BRCA1 mutation carriers were quite different. The authors concluded that BRCA1 carriers who had used oral contraceptives before 1975, before the age of 30 years, ...

BRCA1 and/or BRCA2 tumor pathogenic variants (tPVs) were found in 42 patients, or 15.8% of patients. When compared with patients without BRCA1/2 mutations patients with those mutations were younger ...

One of her daughters, who also has the BRCA1 mutation, was diagnosed with breast cancer at age 26 and opted to have both breasts removed. Because of her young age, ...

Although the extent to which different gene mutations increase a woman’s risk of breast cancer isn’t completely understood, it is known that BRCA1 and BRCA2 mutations carry the highest risk.

In their retrospective study, Rebbeck et al [] concluded that in female BRCA1/2 mutation carriers, a BPO may aid in identifying early stage, more treatable ovarian cancer. For those opting for a ...